| 1 |
Jorns C, Nowak G, Nemeth A, et al. De novo donor-specific HLA antibody formation in two patients with crigler-najjar syndrome type Ⅰ following human hepatocyte transplantation with partial hepatectomy preconditioning[J]. Am J Transplant, 2016, 16(3): 1021-1030.
|
| 2 |
Mizutani K, Terasaki P, Rosen A, et al. Serial ten-year follow-up of HLA and MICA antibody production prior to kidney graft failure[J]. Am J Transplant, 2005, 5(9): 2265-2272.
|
| 3 |
Mizutani K, Terasaki P, Bignon JD, et al. Association of kidney transplant failure and antibodies against MICA[J]. Hum Immunol, 2006, 67(9): 683-691.
|
| 4 |
Panigrahi A, Gupta N, Siddiqui JA, et al. Post transplant development of MICA and anti-HLA antibodies is associated with acute rejection episodes and renal allograft loss[J]. Hum Immunol, 2007, 68(5): 362-367.
|
| 5 |
Bahram S, Bresnahan M, Geraghty DE, et al. A second lineage of mammalian major histocompatibility complex class Ⅰ genes[J]. Proc Natl Acad Sci U S A, 1994, 91(14): 6259-6263.
|
| 6 |
Shiina T, Tamiya G, Oka A, et al. Molecular dynamics of MHC genesis unraveled by sequence analysis of the 1，796，938-bp HLA class Ⅰ region[J]. Proc Natl Acad Sci U S A, 1999, 96(23): 13282-13287.
|
| 7 |
Sawai H, Nishida N, Khor SS, et al. Genome-wide association study identified new susceptible genetic variants in HLA class Ⅰ region for hepatitis B virus-related hepatocellular carcinoma[J]. Sci Rep, 2018, 8:7958.
|
| 8 |
Wang WY, Wang F, Tian W. Identification of a novel MICB allele, MICB*030, by cloning and sequencing[J]. Int J Immunogenet, 2015, 42(4): 292-293.
|
| 9 |
Chen LC, Lan H, Sun L, et al. Genomic organization of the crested ibis MHC provides new insight into ancestral avian MHC structure[J]. Sci Rep, 2015, 5: 7963.
|
| 10 |
Zingoni A, Vulpis E, Cecere F, et al. MICA-129 dimorphism and soluble MICA are associated with the progression of multiple myeloma[J]. Front Immunol, 2018, 9: 926.
|
| 11 |
Bahram S, Spies T. The MIC gene family[J]. Res Immunol, 1996, 147(5): 328-333.
|
| 12 |
Yamakawa RH, Saito PK, Gelmini GF, et al. MICA diversity and linkage disequilibrium with HLA-B alleles in renal-transplant candidates in southern Brazil[J]. PLoS One, 2017, 12(4): e0176072.
|
| 13 |
Luo Q, Guo X, Peng S, et al. The association between MICA/MICB polymorphism and respiratory syncytial virus infection in children[J]. Int J Immunogenet, 2017, 44(6): 328-336.
|
| 14 |
Douik H, Ben Chaaben A, Attia Romdhane N, et al. Association of MICA-129 polymorphism with nasopharyngeal cancer risk in a Tunisian population[J]. Hum Immunol, 2009, 70(1): 45-48.
|
| 15 |
Sohn YH, Cha CH, Oh HB, et al. MICA polymorphisms and haplotypes with HLA-B and HLA-DRB1 in Koreans[J]. Tissue Antigens, 2010, 75(1): 48-55.
|
| 16 |
Hankey KG, Drachenberg CB, Papadimitriou JC, et al. MIC expression in renal and pancreatic allografts[J]. Transplantation, 2002, 73(2): 304-306.
|
| 17 |
Seiler M, Brabcova I, Viklicky O, et al. Heightened expression of the cytotoxicity receptor NKG2D correlates with acute and chronic nephropathy after kidney transplantation[J]. Am J Transplant, 2007, 7(2): 423-433.
|
| 18 |
Chauveau A, Tonnerre P, Pabois A, et al. Endothelial cell activation and proliferation modulate NKG2D activity by regulating MICA expression and shedding[J]. J Innate Immun, 2014, 6(1): 89-104.
|
| 19 |
Sumitran-Holgersson S, Wilczek HE, Holgersson J, et al. Identification of the nonclassical HLA molecules, mica, as targets for humoral immunity associated with irreversible rejection of kidney allografts[J]. Transplantation, 2002, 74(2): 268-277.
|
| 20 |
Togninalli M, Yoneoka D, Kolios AGA, et al. Pretransplant kinetics of anti-HLA antibodies in patients on the waiting list for kidney transplantation[J]. J Am Soc Nephrol, 2019, 30(11): 2262-2274.
|
| 21 |
Lougaris V, Patrizi O, Baronio M, et al. p85α is an intrinsic regulator of human natural killer cell effector functions[J]. J Allergy Clin Immunol, 2016, 138(2): 605-608.
|
| 22 |
Boukouaci W, Al-Daccak R, Dulphy N, et al. Soluble MICA-NKG2D interaction upregulates IFN-gamma production by activated CD3-CD56＋ NK cells: potential impact on chronic graft versus host disease[J]. Hum Immunol, 2013, 74(12): 1536-1541.
|
| 23 |
Croxatto D, Martini S, Chiossone L, et al. IL15 induces a potent antitumor activity in NK cells isolated from malignant pleural effusions and overcomes the inhibitory effect of pleural fluid[J]. Oncoimmunology, 2017, 6(4): e1293210.
|
| 24 |
Jin F, Lin H, Gao S, et al. The anti-tumor role of NK cells in vivo pre-activated and re-stimulated by interleukins in acute lymphoblastic leukemia[J]. Oncotarget, 2016, 7(48): 79187-79202.
|
| 25 |
Roberts AI, Lee L, Schwarz E, et al. NKG2D receptors induced by IL-15 costimulate CD28-negative effector CTL in the tissue microenvironment[J]. J Immunol, 2001, 167(10): 5527-5530.
|
| 26 |
Bauer S, Groh V, Wu J, et al. Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA[J]. Science, 1999, 285(5428): 727-729.
|
| 27 |
Yu R, Xu S, Wang Y, et al. Role of MICA expression, anti-MICA antibodies and serum MICA during acute rejection in a rat-to-mouse cardiac transplantation model[J]. Int J Clin Exp Pathol, 2015, 8(11): 14514-14520.
|
| 28 |
Zhang Y, Stastny P. MICA antigens stimulate T cell proliferation and cell-mediated cytotoxicity[J]. Hum Immunol, 2006, 67(3): 215-222.
|
| 29 |
Zou Y, Mirbaha F, Lazaro A, et al. MICA is a target for complement-dependent cytotoxicity with mouse monoclonal antibodies and human alloantibodies[J]. Hum Immunol, 2002, 63(1): 30-39.
|
| 30 |
Wang S, Zhang C, Wang J, et al. Endothelial cells in antibody-mediated rejection of kidney transplantation: pathogenesis mechanisms and therapeutic implications[J]. J Immunol Res, 2017: 8746303.
|
| 31 |
Zou Y, Stastny P, Susal C, et al. Antibodies against MICA antigens and kidney-transplant rejection[J]. N Engl J Med, 2007, 357(13): 1293-1300.
|
| 32 |
Mizutani K, Terasaki PI, Shih RN, et al. Frequency of MIC antibody in rejected renal transplant patients without HLA antibody[J]. Hum Immunol, 2006, 67(3): 223-229.
|
| 33 |
Solgi G, Furst D, Mytilineos J, et al. Clinical relevance of pre and post-transplant immune markers in kidney allograft recipients: anti-HLA and MICA antibodies and serum levels of sCD30 and sMICA[J]. Transpl Immunol, 2012, 26(2-3): 81-87.
|
| 34 |
Seyhun Y, Ozdilli K, Oguz F, et al. Human leukocyte antigen and major histocompatibility complex class Ⅰ-related chain A antibodies after kidney transplantation in Turkish renal transplant recipients[J]. Transplant Proc, 2012, 44(6): 1660-1666.
|
| 35 |
Chaudhuri A, Ozawa M, Everly MJ, et al. The clinical impact of humoral immunity in pediatric renal transplantation[J]. J Am Soc Nephrol, 2013, 24(4): 655-664.
|
| 36 |
Zhang LW, Peng ZG, Xian WH, et al. Association of de novo human leukocyte antigen and major histocompatibility complex class Ⅰ chain-related gene-A antibodies and proteinuria with graft survival 5 years after renal transplantation[J]. Transplant Proc, 2013, 45(9): 3249-3253.
|
| 37 |
Terasaki PI, Ozawa M, Castro R. Four-year follow-up of a prospective trial of HLA and MICA antibodies on kidney graft survival[J]. Am J Transplant, 2007, 7(2): 408-415.
|
| 38 |
Ozawa M, Terasaki PI, Lee JH, et al. 14th International HLA and Immunogenetics Workshop: report on the prospective chronic rejection project[J]. Tissue Antigens, 2007, 69(Suppl 1): S174-S179.
|
| 39 |
Yao QC, Wang W, Li XB, et al. Expression characteristics of major histocompatibility complex class Ⅰ-related chain A antibodies and immunoadsorption effect in sensitized recipients of kidney transplantation[J]. Chin Med J (Engl), 2011, 124(5): 669-673.
|
| 40 |
Zhang M, Lu FM, Qu LX, et al. Serum major-histocompatibility-complex class Ⅰ-related chain A antibody detection for the evaluation of graft dysfunction in renal allograft recipients[J]. Chin Med J (Engl), 2011, 124(14): 2127-2131.
|